Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

171.68
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
160.07
Today|||52-Week Range
256.80
-18.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line1.2M-2.6B-723.9M-4.0B
 
 
 
 
 
Depreciation1.7B1.8B1.8B1.8B
 
 
 
 
 
Total Other Cash Flow-415.1M2.5B866.8M5.5B
 
 
 
 
 
Funds From Operations342.9M959.1M1.2B1.6B
 
 
 
 
 
Funds From/For Other Operating Expenses426.2M235.8M-454.9M125.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-83.3M723.3M1.6B1.5B
 
 
 
 
 
 
InvestingIncrease In Investments-298.0M-6.4B-400.0M-1.6B
 
 
 
 
 
Capital Expenditures-80.9M-33.2M-104.0M-96.8M
 
 
 
 
 
Fixed Asset Disposal499.7M700.0K3.6M1.5M
 
 
 
 
 
Net Assets From Acquisitions -1.1B-2.9B-2.4B0.00
 
 
 
 
Other Investing - Sources7.7B9.7B3.5B1.3B
 
 
 
 
 
Net Cash Flow Investing6.7B14.2M385.8M-482.3M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.000.003.0B2.0M
 
 
 
Long Term Debt Reduction-17.7M-1.0B-4.6B0.00
 
 
 
 
Net Proceeds Stock Sale34.1M52.6M72.1M42.5M
 
 
 
 
 
Common Preferred Redeemed-12.3B-29.5M-5.7M-1.2M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-69.6M-305.8M-306.1M-305.1M
 
 
 
 
 
Other Sources - Financing-6.2M------
 
 
Other Uses - Financing83.4M76.3M428.8M10.1M
 
 
 
 
 
Net Cash Flow - Financing-12.5B-1.4B-2.2B-271.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-12.8M6.3M5.2M7.6M
 
 
 
 
 
 
Net Change In Cash-5.8B-637.4M-211.2M718.2M